Loading stock data…
HIMS
$27.41+0.24 (+0.88%)
Market ClosedLast close May 1
Hims & Hers Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Hims & Hers Health, Inc. in the Healthcare sector is trading at $27.41. The stock is currently 61% below its 52-week high of $70.43, remaining 26.6% below its 200-day moving average. Technical signals show neutral RSI of 65 and bearish MACD signal, explaining why HIMS maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 65) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$27.41
Potential Downside
55.8%
Whystock Fair Value$12.12
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus14 analysts
Hold
Mean target$26.25-4.2%
Range$18.00 – $35.00
Fundamentals
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and int...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$6.61B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
56.88
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.31
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
35.79%
Volume
Today's trading volume
14.28M
Recent News
Data Breach Lawsuits Test Hims And Hers Health Valuation And Momentum
Two class action lawsuits claim Hims & Hers Health did not adequately safeguard sensitive customer data during recent data breaches. The suits allege delayed notification to affected customers and increased risk of identity theft, and they seek damages plus stronger data security oversight. These cases introduce fresh legal and reputational questions for NYSE:HIMS that have not been widely covered so far. For investors watching NYSE:HIMS, this legal development adds a new angle to a stock...
HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now?
Hims & Hers and Teladoc Health are taking different paths in digital health, but which stock offers stronger upside now? Let's dive in.
Hims & Hers Expands Digital-First Access to Personalized Healthcare
HIMS broadens digital-first care with Novo Nordisk GLP-1 access, new cancer detection and Labs tools, along with expansion into Canada and Europe.
Hims & Hers Health, Inc. (HIMS) is a Top-Ranked Momentum Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 4% in the afternoon session after the stock's momentum weakened as Amazon.com entered the weight management market through its One Medical platform.